MYDAYIS® (Mixed Salts of a Single-Entity Amphetamine)

MYDAYIS® is a brand-name medication that contains mixed salts of a single-entity amphetamine. It is primarily used to treat attention deficit hyperactivity disorder (ADHD) in pediatric and adult patients.  MYDAYIS® is a central nervous system stimulant. It works by affecting certain chemicals in the brain and nerves that contribute to hyperactivity and impulse control.

Indications and Uses

MYDAYIS® is indicated for the following purposes:

• Treatment of attention deficit hyperactivity disorder (ADHD) in pediatric patients aged 13 years and older and in adult patients.

• It is used to improve attention and reduce impulsiveness and hyperactivity.

Dosage and Administration

The dosage of MYDAYIS® is determined by a healthcare provider based on the patient's specific condition. The medication is taken orally, typically once daily in the morning. The dose may be adjusted over time for optimal symptom control.

Contraindications

MYDAYIS® should not be used in individuals with known hypersensitivity to amphetamines or any of its components. It is essential to discuss any allergies or potential reactions with a healthcare provider.

Adverse Effects and Side Effects

Common side effects of MYDAYIS® may include:

• Insomnia.

• Decreased appetite.

• Increased heart rate.

• Dry mouth.

• Nervousness.

Serious side effects are possible and may include:

• Cardiovascular effects, such as increased blood pressure or heart rate.

• Mental/mood changes, such as agitation or aggression.

• Circulation problems.

• Uncontrolled movements or vocal outbursts (tics).

• Peripheral vasculopathy.

• Growth reduction in children.

It is crucial to report any severe or unusual side effects to your healthcare provider.

Storage and Shelf Life

Store MYDAYIS® at room temperature (20-25°C or 68-77°F). Protect it from excessive heat and moisture. Do not use MYDAYIS® after the expiration date.

Packaging and Presentation

MYDAYIS® is available in capsule form, with various strengths of amphetamine salts.

Regulatory Information

MYDAYIS® is subject to regulation by health authorities to ensure its safety and efficacy. It is essential to use this medication as directed by a healthcare professional and in accordance with local regulations.

References

Always consult with your healthcare provider and refer to the official prescribing information and product labeling for the most up-to-date and comprehensive information on MYDAYIS®. Your healthcare provider will guide you in the proper use of this medication, monitor your progress, and tailor the treatment to your specific medical condition.